The stock closed at $146.46 on Wednesday, snapping a five-day winning streak and finishing 14.35% below its 52-week high.
Trading volume was 8.5 million, about 1.9 million below its 50-day average, as the S&P 500 and Dow Jones also declined.
Procter & Gamble underperformed competitors like Johnson & Johnson, Estee Lauder, and Colgate-Palmolive during the session, reflecting a generally weak day for the stock market.
With its stock undervalued but facing major headwinds, is P&G a smart buy or a value trap?
Following strong earnings but cautious guidance, what is P&G's true outlook for the rest of 2026?
Will declining margins force P&G to choose between its dividend streak and crucial innovation investments?
As consumers feel the pinch, will private label brands finally break P&G's market dominance?
Amidst market volatility, how are predatory 'mini-tender' offers targeting retail investors?
How can P&G thrive when its 'average consumer' no longer exists in a K-shaped economy?